-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ENibulCWQ80Dzje+MbSQUgECAx4TwA1MM/T7GKbYywrfXTQGTHO9tFBKOYkJ+QRI hNt93q836RObqKJj+3sz3w== 0001447348-09-000015.txt : 20091005 0001447348-09-000015.hdr.sgml : 20091005 20091005160404 ACCESSION NUMBER: 0001447348-09-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20091001 FILED AS OF DATE: 20091005 DATE AS OF CHANGE: 20091005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Mark Robert CENTRAL INDEX KEY: 0001331438 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 091105659 MAIL ADDRESS: STREET 1: 120 STATE STREET CITY: BROOKLYN STATE: NY ZIP: 11201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-10-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001331438 Baker Mark Robert 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 General Counsel Common Stock 2009-10-01 4 M 0 3999 4.259 A 33554 D Common Stock 2009-10-01 4 F 0 3639 5.01 D 29915 D ESPP (right to buy) 4.259 2009-10-01 4 M 0 3999 0 D 2009-10-01 2009-10-01 Common Stock 3999 0 D ESPP (right to buy) 5.24 2009-10-01 4 A 0 3399 0 A 2010-04-01 2010-04-01 Common Stock 3399 3399 D Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date. By: Robert A. McKinney For: Mark R. Baker 2009-10-05 EX-24 2 bakerpoa.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of Mark R. Baker and Robert A. McKinney, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to: prepare, execute and submit to the U.S. Securities and Exchange Commission (SEC), in the undersigned's name and on the undersigned's behalf, a Form ID, amendments thereto and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 (Exchange Act) and the rules and regulations promulgated thereunder as a result of the undersigned's capacity as an officer and/or director of, and/or ownership of and/or transactions in securities of, Progenics Pharmaceuticals, Inc. (the Company); prepare, execute and submit to or file with the SEC and any stock exchange or other authority, for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with said Section, rules and regulations, and do and perform any and all other acts for and on behalf of the undersigned which may be necessary or desirable in connection therewith; and take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, or in the best interest or legally required of, the undersigned, the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney being in such form and containing such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that neither the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, nor the Company are assuming any of the undersigned's responsibilities to comply with the Exchange Act or any rule or regulation promulgated thereunder. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or their substitute or substitutes. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 6th day of July, 2009. /s/ Mark R. Baker Signature Mark R. Baker Print Name \\\DC - 57385/2 - #1301253 v1 \\\DC - 57385/2 - #1301253 v1 -----END PRIVACY-ENHANCED MESSAGE-----